Indonesia · Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.81 trillion. The enterprise value is 1.39 trillion.
| Market Cap | 1.81T |
| Enterprise Value | 1.39T |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 6.12.
| PE Ratio | 6.12 |
| Forward PE | n/a |
| PS Ratio | 1.43 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | 4.30 |
| P/OCF Ratio | 4.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.30, with an EV/FCF ratio of 3.30.
| EV / Earnings | 4.68 |
| EV / Sales | 1.09 |
| EV / EBITDA | 3.30 |
| EV / EBIT | 3.61 |
| EV / FCF | 3.30 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.91 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 221.14 |
Financial Efficiency
Return on equity (ROE) is 31.79% and return on invested capital (ROIC) is 46.47%.
| Return on Equity (ROE) | 31.79% |
| Return on Assets (ROA) | 20.82% |
| Return on Invested Capital (ROIC) | 46.47% |
| Return on Capital Employed (ROCE) | 34.91% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | 3.50B |
| Profits Per Employee | 817.35M |
| Employee Count | 362 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, PT Merck Tbk has paid 97.87 billion in taxes.
| Income Tax | 97.87B |
| Effective Tax Rate | 24.86% |
Stock Price Statistics
The stock price has increased by +12.22% in the last 52 weeks. The beta is 0.22, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +12.22% |
| 50-Day Moving Average | 3,605.00 |
| 200-Day Moving Average | 3,172.55 |
| Relative Strength Index (RSI) | 54.75 |
| Average Volume (20 Days) | 133,660 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.27 trillion and earned 295.88 billion in profits. Earnings per share was 660.45.
| Revenue | 1.27T |
| Gross Profit | 621.85B |
| Operating Income | 384.15B |
| Pretax Income | 393.75B |
| Net Income | 295.88B |
| EBITDA | 410.04B |
| EBIT | 384.15B |
| Earnings Per Share (EPS) | 660.45 |
Balance Sheet
The company has 443.14 billion in cash and 18.62 billion in debt, with a net cash position of 424.52 billion or 947.58 per share.
| Cash & Cash Equivalents | 443.14B |
| Total Debt | 18.62B |
| Net Cash | 424.52B |
| Net Cash Per Share | 947.58 |
| Equity (Book Value) | 1.04T |
| Book Value Per Share | 2,323.42 |
| Working Capital | 875.16B |
Cash Flow
In the last 12 months, operating cash flow was 440.20 billion and capital expenditures -19.77 billion, giving a free cash flow of 420.43 billion.
| Operating Cash Flow | 440.20B |
| Capital Expenditures | -19.77B |
| Depreciation & Amortization | 25.88B |
| Net Borrowing | -7.79B |
| Free Cash Flow | 420.43B |
| FCF Per Share | 938.46 |
Margins
Gross margin is 49.02%, with operating and profit margins of 30.28% and 23.32%.
| Gross Margin | 49.02% |
| Operating Margin | 30.28% |
| Pretax Margin | 31.04% |
| Profit Margin | 23.32% |
| EBITDA Margin | 32.32% |
| EBIT Margin | 30.28% |
| FCF Margin | 33.14% |
Dividends & Yields
This stock pays an annual dividend of 170.00, which amounts to a dividend yield of 4.21%.
| Dividend Per Share | 170.00 |
| Dividend Yield | 4.21% |
| Dividend Growth (YoY) | -46.88% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 25.62% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.27% |
| Earnings Yield | 16.35% |
| FCF Yield | 23.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
PT Merck Tbk has an Altman Z-Score of 6.74 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.74 |
| Piotroski F-Score | 6 |